Skip to content

Your Account & Services
- Manage Account
- Account Settings
- Current Subscriptions
- Motley Fool Premium UK
- HUB Motley Fool UK Premium Hub

Member Login

Investing
- - - Market News
    - Latest Investing News
    - FTSE Today
    - Free Investing Reports
  - - Learn How To Invest
    - How The Stock Market Works
    - Investing Definitions to Know
    - Types of Shares
    - Guide to Market Sectors
  - - Start Investing in the UK
    - How to Get Started Investing
    - What to Invest In
    - How To Buy Shares
    - Get Our Latest Recommendations
  - - Compare Brokers
    - Compare Share Dealing Accounts
    - Compare Stocks and Shares ISAs
    - Compare Robo-Advisors
    - Compare Trading Apps
Retirement
- - - Learn More About Pensions
    - How do pensions work?
    - Do you need a financial advisor for your pension?
    - Pensions vs. ISAs
    - Are pensions taxable?
Services
- - - Premium Investing Services
    - Share Advisor
    - Hidden Winners
    - Pro
  - - Bespoke Investing Strategy Services
    - The Ownership Portfolio UK
    - Blast Off UK
    - Microcap Mission UK
    - Extreme Opportunities UK
Personal Finance
- - - Credit Cards
    - Guide to Rewards & Cashback Credit Cards
    - Guide to Business Credit Cards
  - - Savings
    - Guide to Savings Accounts
    - Savings Calculator
  - - Insurance
    - Guide to Insurance
    - Guide to Car Insurance
  - - Mortgages
    - Guide to Mortgages
    - Mortgage Calculator
About
- - - Legal, Privacy & Terms
    - Legal Information
    - Disclaimer & Disclosure
    - Privacy & Cookie Statement
    - GDPR Request Centre
    - Terms & Conditions
  - - Work For Us
    - Fool Careers
  - - Looking For Something Else?
    - Frequently Asked Questions
    - Site Map

Stocks

/

AbCellera Biologics Inc. (NASDAQ: ABCL)

/

NASDAQ:ABCL (AbCellera Biologics Inc.)

About ABCL

AbCellera Biologics Inc.

Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Financial Market Data copyright © 2022 QuoteMedia. Market Data powered by QuoteMedia. Profiles by Morningstar. Terms of Use.

Financial Market Data copyright © 2022 QuoteMedia. Market Data powered by QuoteMedia. Financials by Morningstar. Terms of Use.

Financial Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Financial Market Data copyright © 2022 QuoteMedia. Market Data powered by QuoteMedia. Share Information by Morningstar. Terms of Use.

Financial Market Data copyright © 2022 QuoteMedia. Market Data powered by QuoteMedia. Dividends by EDI/Mergent (USA) and TSX (CDN). Terms of Use.

Financial Market Data copyright © 2022 QuoteMedia. Market Data powered by QuoteMedia. Earnings and Analyst Ratings by Zacks. Earnings Events by Wall Street Horizon. Terms of Use.

AbCellera Biologics Inc. (NASDAQ: ABCL) Latest News

No posts found.

About The Motley Fool UK

Our Purpose

To make the world Smarter, Happier, And Richer

Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show and premium investing services.

Read more about us >

News
Education
The Fool UK Team
Retirement
Services
Fool Careers
Site Map
Contact Us

Disclaimer and Disclosure
Privacy and Cookie Statement
Terms and Conditions
Legal Information
GDPR

Manage Account

Get FREE issues of The Motley Fool Collective

Do you want straightforward views on what’s happening with the stock market, direct to your inbox? Help yourself with our FREE email newsletter designed to help you protect and grow your portfolio.

Email

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.

RISK WARNINGS AND DISCLAIMERS

We have taken reasonable steps to ensure that any information provided by The Motley Fool Ltd, is accurate at the time of publishing. Any opinions expressed are the opinions of the authors only. The content provided has not taken into account the particular circumstances of any specific individual or group of individuals and does not constitute personal advice or a personal recommendation. No content should be relied upon as constituting personal advice or a personal recommendation, when making your decisions. If you require any personal advice or recommendations, please speak to an independent qualified financial adviser. No liability is accepted by the author, The Motley Fool Ltd or Richdale Brokers and Financial Services Ltd for any loss or detriment experienced by any individual from any decision, whether consequent to, or in any way related to the content provided by The Motley Fool Ltd; the provision of which is an unregulated activity.

The value of stocks, shares and any dividend income may fall as well as rise and is not guaranteed, so you may get back less than you invested. You should not invest any money you cannot afford to lose, and you should not rely on any dividend income to meet your living expenses. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, administrative costs, withholding taxes and different accounting and reporting standards. They may have other tax implications, and may not provide the same, or any, regulatory protection. Exchange rate charges may adversely affect the value of shares in sterling terms, and you could lose money in sterling even if the stock price rises in the currency of origin. Any performance statistics that do not adjust for exchange rate changes are likely to result in an inaccurate portrayal of real returns for sterling-based investors.

Fool and The Motley Fool are both trading names of The Motley Fool Ltd. The Motley Fool Ltd is an appointed representative of Richdale Brokers & Financial Services Ltd who are authorised and regulated by the Financial Conduct Authority (FCA) (FRN: 422737). We publish information, opinion and commentary about consumer credit products, loans, mortgages, insurance, savings and investment products and services, including those of our affiliate partners.

The Motley Fool Ltd. Registered Office: 5 New Street Square, London EC4A 3TW. | Registered in England & Wales. Company No: 3736872. VAT Number: 188035783.

© 1998 – 2025 The Motley Fool. All rights reserved. The Motley Fool, Fool, and the Fool logo are registered trademarks of The Motley Fool Holdings Inc.